Latest Breaking News On - Viewpoint molecular targeting inc - Page 1 : comparemela.com

Perspective Therapeutics Reports First Quarter Fiscal 2023 Results

Perspective Therapeutics Reports First Quarter Fiscal 2023 Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Thijs spoorLifesci advisorschuck padalaPerspective therapeutics incViewpoint molecular targeting incIsoray medical incWall streetPerspective therapeuticDose escalation studiesPerspective therapeuticsRelations contactInc perspective therapeuticsHarbor statementstatementsViewpoint molecular targetingIsoray medicalPrivate securities litigation reform act

Viewpoint Molecular Targeting (CATX) and PharmaLogic Collaborate for Production of theranostics for Cancer Care

Viewpoint Molecular Targeting (CATX) and PharmaLogic Collaborate for Production of theranostics for Cancer Care
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesScott holbrookChris parrThijs spoorPerspective therapeutics incMaster services agreementViewpoint molecular targeting incDrug administrationPharmalogic holdings corpLogic holdingsViewpoint molecular targetingPerspective therapeuticsChief strategy officerGeneral managerPerspective therapeuticVice president

Perspective Therapeutics and PharmaLogic announce collaboration for the development and production of theranostics for cancer care

/PRNewswire/ PharmaLogic Holdings Corp. ("PharmaLogic" or "the Company"), a contract development and manufacturing organization and radiopharmaceutical.

United statesScott holbrookChris parrThijs spoorMaster services agreementPerspective therapeutics incDrug administrationViewpoint molecular targeting incIsoray incPrnewswire pharmalogic holdings corpPharmalogic holdings corpLogic holdingsViewpoint molecular targetingPerspective therapeuticsChief strategy officerGeneral manager

Perspective Therapeutics Announces the Awarding of a $1 million Collaborative Grant to King s College London to Support Radiobiology Research of Alpha Particle Therapy for Cancer

Perspective Therapeutics Announces the Awarding of a $1 million Collaborative Grant to King s College London to Support Radiobiology Research of Alpha Particle Therapy for Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofSamantha terryMichael schultzChuck padalaKing college londonPerspective therapeutics incUnited kingdom medical research councilUnited kingdom researchViewpoint molecular targeting incIsoray incResearch councilProfessor senior lecturer at king college londonMedical research councilUnited kingdom innovationPerspective therapeutic

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

United kingdomCity ofSamantha terryMichael schultzChuck padalaKing college londonPerspective therapeutics incUnited kingdom medical research councilUnited kingdom researchViewpoint molecular targeting incIsoray incProfessor senior lecturer at king college londonResearch councilMedical research councilUnited kingdom innovationPerspective therapeutic